Screening Appointments Available Now!

Screening Appointments Available Now!

Study Number

8500-729 3

Group

3

Gender

both

Age

20 - 70

Location

Daytona Beach, Florida

Compensation

$11,453

Study Dates

Feb. 18 - May 01, 2023

Additional Information

The investigational drug in this research study is being developed for the potential treatment of patients with obesity or type 2 diabetes. The purpose of this study is to evaluate safety, tolerability, how much of the study drug gets into the bloodstream and how long the body takes to get rid of it following multiple doses in combination with tirzepatide. Tirzepatide is a medication intended to help control blood sugar levels in patients with type 2 diabetes. In addition, body weight, appetite, waist and hip circumference, and the amount of time it takes for substances to move through the stomach (stomach emptying) will be evaluated. 

 

Labcorp Daytona Beach is recruiting for:

- Healthy Men and Women of Non-childbearing potential, age 20-70

- Body Mass Index between 27-45

- Study involves 3 separate stays totaling 9 nights, 4 out-patient visits & 1 phone call

- Compensation up to $11,453 may be provided for time and participation

- Receive up to $300 per qualified participant

Details

Call Now to Schedule Your Screening Appointment! 

Check-in: Feb 18
Check-out: Feb 22

Follow up Visit: Feb 27

Phone Call: Mar 1

Check-in: Mar 5
Check-out: Mar 8

Follow up Visit: Mar 13

Check-in: Mar 19
Check-out: Mar 21

Follow up Visits: Apr 3 & May 1

Calculate Your BMI!

Your Height:
ft / in
Your Weight:
lbs
Select Measurement System:

Your BMI: result